Guillermo J Ruiz-Delgado et al.
Hematology (Amsterdam, Netherlands), 17(3), 140-143 (2012-06-06)
Twenty-nine consecutive patients with hairy cell leukemia (HCL) were treated in two institutions with interferon (IFN, n = 18) or cladribine (n = 11), between July 1987 and May 2011. Median age was 62 (range 29-83) years; there were 21